查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946600

2026年全球神經刺激設備市場報告

Neurostimulation Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，神經刺激設備市場發展迅速，預計將從2025年的68.6億美元成長到2026年的76.4億美元，複合年成長率達11.4%。過去幾年的成長可歸因於多種因素，例如慢性神經系統疾病盛行率的上升、植入式刺激療法在臨床上的接受度不斷提高、疼痛管理治療通訊協定的擴展、神經系統疾病診斷率的提高以及先進植入技術的廣泛應用。

預計未來幾年神經刺激設備市場將快速成長，到2030年市場規模將達到120.3億美元，複合年成長率（CAGR）為12.0%。預測期內的成長要素包括：對個人化神經調控療法的需求不斷成長、微創神經神經刺激設備的應用日益普及、腦機介面研究投資不斷增加、家庭神經調控療法的推廣以及新型刺激適應症的監管核准不斷提高。預測期內的主要趨勢包括：封閉回路型刺激系統的應用日益廣泛、個性化神經調控療法的使用日益增多、無線和微型植入的整合度不斷提高、外部非侵入性刺激器的應用日益普及以及對長期治療可調節性的日益重視。

預計未來醫療產業需求的成長將推動神經刺激設備市場的發展。醫療產業是一個涵蓋廣泛且複雜的領域，包括眾多致力於提供醫療保健服務、供應醫療產品和促進健康的組織、專業人士和機構。神經刺激設備在該領域發揮著至關重要的作用，尤其是在治療和管理神經系統疾病和慢性疼痛方面。例如，根據英國政府機構國家統計局 (ONS) 於 2023 年 5 月發布的報告，英國醫療保健支出預計將從 2022 年到 2023 年成長 5.6%，較 2022 年的 0.9% 增幅顯著。預計到 2023 年，英國醫療保健支出將達到約 3,221.52 億美元（2,920 億英鎊）。醫療保健產業的擴張正在推動神經刺激設備市場的成長。

神經刺激設備市場的主要企業正致力於研發封閉回路型脊髓刺激（SCS）系統，以提供更貼近患者日常活動的自適應療法。封閉回路型SCS系統能夠感知脊髓沿線的生理訊號，並即時自動調節刺激強度，而非輸出固定的電脈衝。例如，2024年4月，美國醫療技術公司Medtronic）的「Inceptive」封閉回路型可充電脊髓刺激設備獲得FDA核准。該設備能夠即時感知生物訊號，自動調節刺激強度，支援多種波形（包括該公司專有的DTM療法），並相容於全身3T磁振造影掃描。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球神經刺激設備市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 封閉回路型刺激系統的應用日益普及
    • 擴大個人化神經調控療法的應用
    • 無線和小型化植入整合技術的進步
    • 擴大外部非侵入性刺激裝置
    • 更加重視長期照護的可客製化性

第5章 終端用戶產業市場分析

  • 醫院
  • 復健中心
  • 神經科診所
  • 疼痛管理中心
  • 專業醫療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球神經刺激設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球神經刺激設備市場規模、對比及成長率分析
  • 全球神經刺激設備市場表現：規模與成長，2020-2025年
  • 全球神經刺激設備市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 嵌入式設備、外部設備
  • 透過使用
  • 疼痛管理、癲癇、自發性震顫、尿失禁和糞便失禁、憂鬱症、肌肌張力不全症、胃輕癱、帕金森氏症
  • 最終用戶
  • 醫院、復健中心和診所
  • 按類型細分：植入式設備
  • 脊髓刺激設備（SCS）、深部腦部刺激器（DBS）、迷走神經刺激設備（VNS）、薦骨神經刺激器（SNS）
  • 按類型細分：外部設備
  • 經顱磁刺激（TMS）設備、經顱直流電刺激（tDCS）設備、顱電刺激（CES）設備

第10章 區域與國家分析

  • 全球神經刺激設備市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球神經刺激設備市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 孟加拉國市場

第19章 泰國市場

第20章 越南市場

第21章 馬來西亞市場

第22章 新加坡市場

第23章：菲律賓市場

第24章 香港市場

第25章：紐西蘭市場

第26章 台灣市場

第27章 東南亞市場

第28章 西歐市場

第29章英國市場

第30章：德國市場

第31章：法國市場

第32章：義大利市場

第33章：西班牙市場

第34章：奧地利市場

第35章：比利時市場

第36章：丹麥市場

第37章 芬蘭市場

第38章：愛爾蘭市場

第39章：荷蘭市場

第40章：挪威市場

第41章：葡萄牙市場

第42章：瑞典市場

第42章 瑞士市場

第43章 東歐市場

第44章：俄羅斯市場

第45章：捷克市場

第46章：波蘭市場

第47章：羅馬尼亞市場

第48章：烏克蘭市場

第49章 北美市場

第50章：美國市場

第51章 加拿大市場

第52章：墨西哥市場

第53章 南美洲市場

第54章：巴西市場

第55章 智利市場

第56章：阿根廷市場

第57章：哥倫比亞市場

第58章 秘魯市場

第59章 中東市場

第60章：沙烏地阿拉伯市場

第61章：以色列市場

第62章 伊朗市場

第63章 土耳其市場

第64章：阿拉伯聯合大公國市場

第65章：非洲市場

第66章 埃及市場

第67章：奈及利亞市場

第68章 南非市場

第69章 市場監理與投資環境

第70章：競爭格局與公司概況

  • 神經刺激設備市場：競爭格局與市場佔有率（2024 年）
  • 神經刺激設備市場：公司估值矩陣
  • 神經刺激設備市場：公司概況
    • Medtronic plc
    • Cyberonics Inc.
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Nevro Corporation

第71章：其他領先和創新企業

  • Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc.

第72章：全球市場競爭基準分析與儀錶板

第73章：重大併購

第74章：高潛力市場國家、細分市場與策略

  • 2030年神經刺激設備市場：提供新機會的國家
  • 2030年神經刺激設備市場：充滿新機會的細分市場
  • 2030年神經刺激設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第75章附錄

簡介目錄
Product Code: ME3TNDEV04_G26Q1

Neurostimulation devices are medical instruments designed to deliver electrical impulses to specific areas of the nervous system to modulate nerve activity. These devices are typically implanted or placed on the body to treat a range of neurological conditions. Neurostimulation works by altering or blocking pain signals or by stimulating specific neural pathways to restore function. These devices aim to enhance patients' quality of life by providing targeted, adjustable therapy tailored to individual needs.

The primary products in the neurostimulation devices market can be categorized into implantable devices and external devices. Implantable devices include cochlear implants, deep brain stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and gastric electric stimulation devices. External devices encompass transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). These devices are used in a variety of applications, including pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, and Parkinson's disease. They are employed by different healthcare facilities, such as hospitals, rehabilitation centers, and medical clinics.

Tariffs are impacting the neurostimulation devices market by increasing costs of imported electronic components, implantable materials, microcontrollers, sensors, and precision manufacturing equipment used in spinal cord, deep brain, and vagus nerve stimulators. North America and Europe are particularly affected due to reliance on global semiconductor and medical-grade component supply chains, while Asia-Pacific faces cost pressures in export-oriented device manufacturing. These tariffs are increasing production costs and device pricing, which may slow adoption in cost-sensitive healthcare settings. However, tariffs are also encouraging local manufacturing, regional sourcing of electronic components, and investments in domestic medical device production capabilities, strengthening long-term supply chain resilience.

The neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides neurostimulation devices market statistics, including neurostimulation devices industry global market size, regional shares, competitors with a neurostimulation devices market share, detailed neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurostimulation devices industry. This neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurostimulation devices market size has grown rapidly in recent years. It will grow from $6.86 billion in 2025 to $7.64 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing prevalence of chronic neurological disorders, wider clinical acceptance of implantable stimulation therapies, expansion of pain management treatment protocols, growing neurological disease diagnosis rates, availability of advanced implant technologies.

The neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $12.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to increasing demand for personalized neuromodulation therapies, rising adoption of minimally invasive neurostimulation devices, growing investments in brain-computer interface research, expansion of home-based neuromodulation treatments, increasing regulatory approvals for novel stimulation indications. Major trends in the forecast period include increasing adoption of closed-loop neurostimulation systems, rising use of personalized neuromodulation therapies, growing integration of wireless and miniaturized implants, expansion of external non-invasive stimulation devices, enhanced focus on long-term therapy adjustability.

The growing demand within the healthcare industry is expected to drive the expansion of the neurostimulation devices market in the future. The healthcare industry is a broad and complex sector that includes various organizations, professionals, and institutions focused on delivering medical services, healthcare products, and improving overall health. Neurostimulation devices play a crucial role in this sector, especially in treating and managing neurological conditions and chronic pain. For example, in May 2023, a report from the Office for National Statistics, a UK-based government agency, revealed that healthcare spending in the UK increased by 5.6% from 2022 to 2023, compared to a 0.9% growth in 2022. In 2023, UK healthcare expenditure was approximately $322.152 billion (£292 billion). As a result, the expanding healthcare industry is contributing to the growth of the neurostimulation devices market.

Major companies operating in the neurostimulation devices market are concentrating on closed-loop spinal cord stimulation (SCS) systems to provide adaptive therapy that more closely corresponds to patients' everyday movements. Closed-loop SCS involves systems that detect physiological signals along the spinal cord and automatically modify stimulation in real time, rather than delivering fixed-output electrical pulses. For example, in April 2024, Medtronic plc, a US-based healthcare technology company, obtained FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator. The device includes real-time sensing of biological signals, automatically regulates stimulus intensity, supports multiple waveforms (including its proprietary DTM therapy), and enables full-body 3T MRI access.

In November 2024, Medtronic plc, an Ireland-based medical device company, acquired Fortimedix Surgical for an undisclosed sum. Through this acquisition, Medtronic seeks to enhance its surgical and endoscopy portfolio, particularly to support its upcoming Hugo soft-tissue robotic system. Fortimedix is a Netherlands-based company that provides neurostimulation devices.

Major companies operating in the neurostimulation devices market are Medtronic plc, Cyberonics Inc., Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc., MindMaze, NeuroMetrix, Nexeon MedSystems, Nuvectra, Saluda Medical, SPR Therapeutics Inc., Uro Medical Corporation

North America was the largest region in the global neurostimulation devices market in 2025. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurostimulation devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The neurostimulation devices market consists of sales of spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurostimulation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Implantable Devices; External Devices
  • 2) By Application: Pain Management; Epilepsy; Essential Tremor; Urinary and Fecal Incontinence; Depression; Dystonia; Gastroparesis; Parkinson's Disease
  • 3) By End User: Hospitals; Rehabilitation Centers; Medical Clinic
  • Subsegments:
  • 1) By Implantable Devices: Spinal Cord Stimulators (SCS); Deep Brain Stimulators (DBS); Vagus Nerve Stimulators (VNS); Sacral Nerve Stimulators (SNS)
  • 2) By External Devices: Transcranial Magnetic Stimulation (TMS) Devices; Transcranial Direct Current Stimulation (tDCS) Devices; Cranial Electrotherapy Stimulation (CES) Devices
  • Companies Mentioned: Medtronic plc; Cyberonics Inc.; Boston Scientific Corporation; Abbott Laboratories; Nevro Corporation; Neuronetics Inc.; NeuroPace Inc.; NeuroSigma Inc.; NDI Medical LLC; Synapse Biomedical Inc.; MED-EL; LivaNova PLC; Aleva Neurotherapeutics; BrainsWay; Cortec Corporation; Endonovo Therapeutics Inc.; Inspire Medical Systems Inc.; The Magstim Company Limited; Mainstay Medical Limited; MicroTransponder Inc.; MindMaze; NeuroMetrix; Nexeon MedSystems; Nuvectra; Saluda Medical; SPR Therapeutics Inc.; Uro Medical Corporation
  • Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neurostimulation Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neurostimulation Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neurostimulation Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neurostimulation Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Closed-Loop Neurostimulation Systems
    • 4.2.2 Rising Use Of Personalized Neuromodulation Therapies
    • 4.2.3 Growing Integration Of Wireless And Miniaturized Implants
    • 4.2.4 Expansion Of External Non-Invasive Stimulation Devices
    • 4.2.5 Enhanced Focus On Long-Term Therapy Adjustability

5. Neurostimulation Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Rehabilitation Centers
  • 5.3 Neurology Clinics
  • 5.4 Pain Management Centers
  • 5.5 Specialty Medical Centers

6. Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurostimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neurostimulation Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neurostimulation Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neurostimulation Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurostimulation Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurostimulation Devices Market Segmentation

  • 9.1. Global Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Devices, External Devices
  • 9.2. Global Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease
  • 9.3. Global Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Rehabilitation Centers, Medical Clinic
  • 9.4. Global Neurostimulation Devices Market, Sub-Segmentation Of Implantable Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS)
  • 9.5. Global Neurostimulation Devices Market, Sub-Segmentation Of External Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Cranial Electrotherapy Stimulation (CES) Devices

10. Neurostimulation Devices Market Regional And Country Analysis

  • 10.1. Global Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurostimulation Devices Market

  • 11.1. Asia-Pacific Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurostimulation Devices Market

  • 12.1. China Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurostimulation Devices Market

  • 13.1. India Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurostimulation Devices Market

  • 14.1. Japan Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurostimulation Devices Market

  • 15.1. Australia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurostimulation Devices Market

  • 16.1. Indonesia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurostimulation Devices Market

  • 17.1. South Korea Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Bangladesh Neurostimulation Devices Market

  • 18.1. Bangladesh Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Thailand Neurostimulation Devices Market

  • 19.1. Thailand Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Vietnam Neurostimulation Devices Market

  • 20.1. Vietnam Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Malaysia Neurostimulation Devices Market

  • 21.1. Malaysia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Singapore Neurostimulation Devices Market

  • 22.1. Singapore Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Philippines Neurostimulation Devices Market

  • 23.1. Philippines Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Hong Kong Neurostimulation Devices Market

  • 24.1. Hong Kong Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. New Zealand Neurostimulation Devices Market

  • 25.1. New Zealand Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Taiwan Neurostimulation Devices Market

  • 26.1. Taiwan Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Taiwan Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. South East Asia Neurostimulation Devices Market

  • 27.1. South East Asia Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. South East Asia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Western Europe Neurostimulation Devices Market

  • 28.1. Western Europe Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. Western Europe Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. UK Neurostimulation Devices Market

  • 29.1. UK Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Germany Neurostimulation Devices Market

  • 30.1. Germany Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. France Neurostimulation Devices Market

  • 31.1. France Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Italy Neurostimulation Devices Market

  • 32.1. Italy Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Spain Neurostimulation Devices Market

  • 33.1. Spain Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Austria Neurostimulation Devices Market

  • 34.1. Austria Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Belgium Neurostimulation Devices Market

  • 35.1. Belgium Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Denmark Neurostimulation Devices Market

  • 36.1. Denmark Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

37. Finland Neurostimulation Devices Market

  • 37.1. Finland Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

38. Ireland Neurostimulation Devices Market

  • 38.1. Ireland Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

39. Netherlands Neurostimulation Devices Market

  • 39.1. Netherlands Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40. Norway Neurostimulation Devices Market

  • 40.1. Norway Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

41. Portugal Neurostimulation Devices Market

  • 41.1. Portugal Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Sweden Neurostimulation Devices Market

  • 42.1. Sweden Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Switzerland Neurostimulation Devices Market

  • 42.1. Switzerland Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

43. Eastern Europe Neurostimulation Devices Market

  • 43.1. Eastern Europe Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 43.2. Eastern Europe Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

44. Russia Neurostimulation Devices Market

  • 44.1. Russia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

45. Czech Republic Neurostimulation Devices Market

  • 45.1. Czech Republic Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

46. Poland Neurostimulation Devices Market

  • 46.1. Poland Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

47. Romania Neurostimulation Devices Market

  • 47.1. Romania Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

48. Ukraine Neurostimulation Devices Market

  • 48.1. Ukraine Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

49. North America Neurostimulation Devices Market

  • 49.1. North America Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 49.2. North America Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50. USA Neurostimulation Devices Market

  • 50.1. USA Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 50.2. USA Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

51. Canada Neurostimulation Devices Market

  • 51.1. Canada Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 51.2. Canada Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

52. Mexico Neurostimulation Devices Market

  • 52.1. Mexico Neurostimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 52.2. Mexico Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

53. South America Neurostimulation Devices Market

  • 53.1. South America Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 53.2. South America Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

54. Brazil Neurostimulation Devices Market

  • 54.1. Brazil Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

55. Chile Neurostimulation Devices Market

  • 55.1. Chile Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

56. Argentina Neurostimulation Devices Market

  • 56.1. Argentina Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

57. Colombia Neurostimulation Devices Market

  • 57.1. Colombia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

58. Peru Neurostimulation Devices Market

  • 58.1. Peru Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

59. Middle East Neurostimulation Devices Market

  • 59.1. Middle East Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 59.2. Middle East Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

60. Saudi Arabia Neurostimulation Devices Market

  • 60.1. Saudi Arabia Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

61. Israel Neurostimulation Devices Market

  • 61.1. Israel Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

62. Iran Neurostimulation Devices Market

  • 62.1. Iran Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

63. Turkey Neurostimulation Devices Market

  • 63.1. Turkey Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

64. United Arab Emirates Neurostimulation Devices Market

  • 64.1. United Arab Emirates Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

65. Africa Neurostimulation Devices Market

  • 65.1. Africa Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 65.2. Africa Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

66. Egypt Neurostimulation Devices Market

  • 66.1. Egypt Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

67. Nigeria Neurostimulation Devices Market

  • 67.1. Nigeria Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

68. South Africa Neurostimulation Devices Market

  • 68.1. South Africa Neurostimulation Devices Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

69. Neurostimulation Devices Market Regulatory and Investment Landscape

70. Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 70.1. Neurostimulation Devices Market Competitive Landscape And Market Share 2024
    • 70.1.1. Top 10 Companies (Ranked by revenue/share)
  • 70.2. Neurostimulation Devices Market - Company Scoring Matrix
    • 70.2.1. Market Revenues
    • 70.2.2. Product Innovation Score
    • 70.2.3. Brand Recognition
  • 70.3. Neurostimulation Devices Market Company Profiles
    • 70.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.2. Cyberonics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.5. Nevro Corporation Overview, Products and Services, Strategy and Financial Analysis

71. Neurostimulation Devices Market Other Major And Innovative Companies

  • Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc.

72. Global Neurostimulation Devices Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The Neurostimulation Devices Market

74. Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 74.1 Neurostimulation Devices Market In 2030 - Countries Offering Most New Opportunities
  • 74.2 Neurostimulation Devices Market In 2030 - Segments Offering Most New Opportunities
  • 74.3 Neurostimulation Devices Market In 2030 - Growth Strategies
    • 74.3.1 Market Trend Based Strategies
    • 74.3.2 Competitor Strategies

75. Appendix

  • 75.1. Abbreviations
  • 75.2. Currencies
  • 75.3. Historic And Forecast Inflation Rates
  • 75.4. Research Inquiries
  • 75.5. The Business Research Company
  • 75.6. Copyright And Disclaimer